AZN vs HBT · P/E 28, $288.38B cap vs P/E 11, rev $160.4M
AstraZeneca PLC (AZN) versus Hbt Financial Inc (HBT) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Hbt Financial Inc (HBT) is a banks - regional company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported HBT revenue for 2026-06-30 was $160.4M. Net income was $39.0M. HBT currently screens at market cap $828.6M and trailing P/E 10.8.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. HBT currently screens at market cap $828.6M and trailing P/E 10.8.
Not investment advice. Open the AZN and HBT stock pages for the full models.
Not investment advice.